Navigation Links
Genetic differences in clover make one type toxic
Date:10/1/2007

That clover necklace you make for your child could well be a ring of poison. Thats because some clovers have evolved genes that help the plant produce cyanide to protect itself against little herbivores, such as snails, slugs and voles, that eat clover. Other clover plants that do not make cyanide are found in climates with colder temperatures. So, in picking your poison, er, clover, ecology and geography play important roles.

A plant evolutionary biologist at Washington University in St. Louis is trying to get to the bottom of this botanical cloak and dagger tale. Kenneth Olsen, Ph.D., Washington University assistant professor of biology in Arts & Sciences, is looking at the genetics of a wide variety of white clover plants to determine why some plants do and some plants dont make cyanide what biologists call polymorphism, or two types.

We are documenting the effect of natural selection at the DNA sequence level to understand the molecular evolution of this polymorphism, said Olsen. Usually, researchers study model plants such as Arabidopsis or tobacco to understand genetics. But with clover we have a system where we can look in detail at DNA sequence variation and at the same time have a thorough understanding of the plants ecology.

In a study published the week of Sept. 24 in the journal Molecular Ecology, Olsen and his colleagues report findings on the molecular basis of the cyanide polymorphism.

Cyanide bomb in cell

White clover is native to Europe and Asia and was introduced some 300 years ago in North America. The cold factor-acyanogenic relationship has been known a long time in Europe and Asia and it re-evolved in North America when the plant was introduced, indicating that natural selection was a powerful force in shaping the geographical distributions of the two plant types.

The genetic basis behind cyanide production in clover plants boils down to just two genes.

A cyanogenic plant sets up a little cyanide bomb in the cell, Olsen explained. You have a cyanogenic glucoside basically a sugar with a cyanide group stuck onto it, in the cell vacuole, and then in the cell wall there is an enzyme required to hydrolyze the cyanide. If something damages the cell, these two compounds come into contact with each other and free cyanide is released. One gene, Li, encodes the enzyme, which is called linamarase; another gene, Ac, is responsible for the presence or absence of cyanogenic glucosides.

Olsens recent findings have revealed that plants that do not synthesize linamarase are lacking the Li gene altogether: the genes DNA is absent from genomes of these plants.

Olsen and colleagues are also testing hypotheses on why acyanogenic plants occur in cold climates. One poses that there are fewer herbivores in colder climates.

If a plant can get by without investing in all the resources it takes to be cyanogenic, it can concentrate those resources in other forms of growth and reproduction, then it would be out competing the plants that are cyanogenic, Olsen said.

Suicide not ruled out

The second hypothesis explores the lurid possibility of plant suicide. In hypothesis two, we question the role of frequent frosts. The frosts could cause cell rupture and the release of cyanide leading to autotoxicity. If cyanogenic plants are poisoning themselves in cold climates, then those plants will be at a disadvantage.

To examine both the weather factor and suicide possibility, Olsen and his colleagues are testing different types of clovers in freeze chambers at controlled temperatures to see if survival is higher for either acyanogenic or cyanogenic plants.

The advantage of the clover cyanogenesis system is theres already so much known about its ecology, Olsen said. What were able to do now is get to the molecular level and look at the molecular basis of ecologically important variation.


'/>"/>

Contact: Kenneth Olsen
kolsen@wustl.edu
314-935-7013
Washington University in St. Louis
Source:Eurekalert

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
3. Scientists detect probable genetic cause of some Parkinsons disease cases
4. Mouse brain tumors mimic those in human genetic disorder
5. Genetically modified natural killer immune cells attack, kill leukemia cells
6. Scientists identify genetic pathways essential to RNA interference
7. Ants Genetic Engineering Leads To Species Interdependency
8. Researchers trace evolution to relatively simple genetic changes
9. Genetic Variation Visualization - From EMBL
10. Genetically modified rice in China benefits farmers health, study finds
11. Key mechanism in genetic inheritance during cell division identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... Executive search firm, Slone ... Analytical Services. Harvill is a distinguished life sciences expert with a proven track ... leader in a wide range of services related to laboratory testing and analysis ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture ... added to the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). ... USA ) and the US National Institutes of Health. ... ... Logo ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team ... vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. ... of treating coronary artery disease (CAD). Lam is an assistant professor at the ...
(Date:3/24/2017)... and ROCKVILLE, Md. , March ... of Maxwell Biotech Venture Fund (MBVF), today announced positive ... added to the standard drug therapy regimen in patients ... small molecule drug discovered by scientists at Sequella, Inc. ... Institutes of Health. A total of ...
Breaking Biology Technology: